WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles

Guotai Haitong: Zhiyuan Siasun Robot&Automation Live Verification Efficiency Breakthrough, Siasun Robot&Automation Humanoid Industrialization Speeding Up.

HK Stock Market Move | Store rising price trends or sustain Montage Technology (06809) up over 9% and GigaDevice Semiconductor Inc. (03986) up nearly 5%

HK Stock Market Move | Aluminum stocks continue to rise, JP Morgan says global aluminum inventory will only last 9 days, aluminum prices are expected to exceed $4000 in the coming months.
Guotai Haitong: Zhiyuan Siasun Robot&Automation Live Verification Efficiency Breakthrough, Siasun Robot&Automation Humanoid Industrialization Speeding Up.

HK Stock Market Move | Store rising price trends or sustain Montage Technology (06809) up over 9% and GigaDevice Semiconductor Inc. (03986) up nearly 5%

HK Stock Market Move | Aluminum stocks continue to rise, JP Morgan says global aluminum inventory will only last 9 days, aluminum prices are expected to exceed $4000 in the coming months.

RECOMMEND

400 Companies Queue For Hong Kong IPOs As Q1 Fundraising Tops Global Rankings
16/04/2026

Why The Hang Seng Is Under Pressure While The AI Sector Trades Independently? Three Core Hong Kong AI Assets To Watch
16/04/2026

Holiday Effect Spurs Short‑Term Uptick In Hong Kong Consumer Stocks As Policy Supports Travel Spending
16/04/2026


